Journal
MOLECULAR CELL
Volume 48, Issue 5, Pages 667-680Publisher
CELL PRESS
DOI: 10.1016/j.molcel.2012.09.013
Keywords
-
Categories
Funding
- Ligue Nationale contre le Cancer (Equipe labellisee)
- Agence Nationale pour la Recherche (ANR)
- European Commission [p53]
- Fondation pour la Recherche Medicale (FRM)
- Institut National du Cancer (INCa)
- Canceropole Ile-de-France
- AXA Chair for Longevity Research
- Fondation Bettencourt-Schueller
- LabEx Immuno-Oncology
- Junta de Extremadura-Fondo Social Europeo
- Ligue Nationale contre le Cancer
- Higher Education Commission (HEC) of Pakistan
- Apo-Sys
Ask authors/readers for more resources
In a screen designed to identify novel inducers of autophagy, we discovered that STAT3 inhibitors potently stimulate the autophagic flux. Accordingly, genetic inhibition of STAT3 stimulated autophagy in vitro and in vivo, while overexpression of STAT3 variants, encompassing wild-type, nonphosphorylatable, and extranuclear STAT3, inhibited starvation-induced autophagy. The SH2 domain of STAT3 was found to interact with the catalytic domain of the elF2 alpha kinase 2 ElF2AK2, best known as protein kinase R (PKR). Pharmacological and genetic inhibition of STAT3 stimulated the activating phosphorylation of PKR and consequent elF2 alpha hyperphosphorylation. Moreover, PKR depletion inhibited autophagy as initiated by chemical STAT3 inhibitors or free fatty acids like palmitate. STAT3-targeting chemicals and palmitate caused the disruption of inhibitory STAT3-PKR interactions, followed by PKR-dependent elF2 alpha phosphorylation, which facilitates autophagy induction. These results unravel an unsuspected mechanism of autophagy control that involves STAT3 and PKR as interacting partners.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available